EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.
Engert
Andreas
A
Department of Internal Medicine, University of Cologne, Germany.
Herbrecht
Rauol
R
Santoro
Armando
A
Zinzani
Pier Luigi
PL
Gorbatchevsky
Igor
I
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage* / Q000009:adverse effects; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012061:Relapsing Fever
D000970:Antineoplastic Agents; D007546:Isoquinolines; C086548:pixantrone